Armistice Capital’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Armistice Capital’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,000,000	Closed	-$8.9M	–	83
2017 Q2	$8.9M	Sell	2,000,000 -250,000	-11%	-$1.03M	1.13%	36
2017 Q1	$10.5M	Buy	2,250,000 +550,000	+32%	+$3.19M	2.17%	18
2016 Q4	$10.4M	Buy	1,700,000 +460,000	+37%	+$2.4M	2.45%	14
2016 Q3	$6.83M	Sell	1,240,000 -90,000	-7%	-$421K	2.19%	19
2016 Q2	$5.05M	Sell	1,330,000 -870,000	-40%	-$2.95M	1.92%	23
2016 Q1	$6.07M	Buy	+2,200,000	New	+$7.97M	2.38%	15

Other funds holding SGYP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Armistice Capital's SGYP Position: Q3 2017 in Review

Armistice Capital sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2017, closing a stake of 2,000,000 shares — an estimated $8.9M sold.

Armistice Capital first reported a position in SGYP in Q1 2016 and held it in 6 quarters. The position peaked at $10.5M in Q1 2017. 143 funds tracked by Wall St. Rank hold SGYP as of Q3 2017.

Armistice Capital reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2017 after selling out during the quarter.
Armistice Capital sold 2,000,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2017, an estimated $8.9M.
Armistice Capital first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2016 and held it in 6 quarters.
Armistice Capital's Synergy Pharmaceuticals, Inc Common Stock position peaked at $10.5M in Q1 2017.
143 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2017.

Based on Armistice Capital's 13F filing for Q3 2017, filed 14 Nov 2017.